Shanna Leventhal

1.1k total citations
20 papers, 368 citations indexed

About

Shanna Leventhal is a scholar working on Infectious Diseases, Ecology, Evolution, Behavior and Systematics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Shanna Leventhal has authored 20 papers receiving a total of 368 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Infectious Diseases, 8 papers in Ecology, Evolution, Behavior and Systematics and 8 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Shanna Leventhal's work include Viral Infections and Vectors (13 papers), Viral Infections and Outbreaks Research (9 papers) and Mosquito-borne diseases and control (8 papers). Shanna Leventhal is often cited by papers focused on Viral Infections and Vectors (13 papers), Viral Infections and Outbreaks Research (9 papers) and Mosquito-borne diseases and control (8 papers). Shanna Leventhal collaborates with scholars based in United States, United Kingdom and Sweden. Shanna Leventhal's co-authors include Heinz Feldmann, David W. Hawman, Kimberly Meade‐White, Elaine Haddock, Friederike Feldmann, Atsushi Okumura, Kyle Rosenke, Dana Scott, Greg Saturday and Jesse H. Erasmus and has published in prestigious journals such as Nature Communications, Journal of Clinical Microbiology and eLife.

In The Last Decade

Shanna Leventhal

19 papers receiving 357 citations

Peers

Shanna Leventhal

PHEOH

EEBS

EPIDE

Brady T. Hickerson United States

Agnieszka M. Szemiel United Kingdom

Engin Berber United States

Kwang-Min Yu South Korea

Richard S. Makuch United States

Qilin Xin China

Kaori Terasaki United States

Yudai Kuroda Japan

Laura Hunter United Kingdom

Dionna Scharton United States

Brady T. Hickerson United States

Shanna Leventhal

265 ×0.9

69 ×0.6

PHEOH

57 ×0.6

EEBS

50 ×0.7

EPIDE

37 ×0.8

Citations per year, relative to Shanna Leventhal Shanna Leventhal (= 1×) peers Brady T. Hickerson

Countries citing papers authored by Shanna Leventhal

Since Specialization

Citations

This map shows the geographic impact of Shanna Leventhal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shanna Leventhal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shanna Leventhal more than expected).

Fields of papers citing papers by Shanna Leventhal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shanna Leventhal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shanna Leventhal. The network helps show where Shanna Leventhal may publish in the future.

Co-authorship network of co-authors of Shanna Leventhal

This figure shows the co-authorship network connecting the top 25 collaborators of Shanna Leventhal. A scholar is included among the top collaborators of Shanna Leventhal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shanna Leventhal. Shanna Leventhal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lewis, Matthew, Shanna Leventhal, Chad S. Clancy, et al.. (2025). A replicating RNA vaccine protects against severe fever with thrombocytopenia syndrome virus infection in mice. npj Vaccines. 10(1). 219–219.

Hawman, David W., Shanna Leventhal, Kimberly Meade‐White, et al.. (2025). A replicating RNA vaccine confers protection against Crimean-Congo hemorrhagic fever in cynomolgus macaques. EBioMedicine. 115. 105698–105698. 1 indexed citations

Hawman, David W., Thomas Tipih, Edgar A. Hodge, et al.. (2025). Clade 2.3.4.4b but not historical clade 1 HA replicating RNA vaccine protects against bovine H5N1 challenge in mice. Nature Communications. 16(1). 655–655. 4 indexed citations

Tipih, Thomas, Claude Kwe Yinda, Atsushi Okumura, et al.. (2025). Highly pathogenic avian influenza H5N1 clade 2.3.4.4b genotype B3.13 is highly virulent for mice, rapidly causing acute pulmonary and neurologic disease. Nature Communications. 16(1). 5738–5738. 1 indexed citations

Tipih, Thomas, Shanna Leventhal, Kimberly Meade‐White, et al.. (2025). Single dose VSV-based vaccine protects mice against lethal heterologous Crimean-Congo hemorrhagic fever virus challenge. npj Vaccines. 10(1). 109–109. 2 indexed citations

Leventhal, Shanna, Dean Clift, Kimberly Meade‐White, et al.. (2024). Antibodies targeting the Crimean-Congo Hemorrhagic Fever Virus nucleoprotein protect via TRIM21. Nature Communications. 15(1). 9236–9236. 6 indexed citations

Hawman, David W., Shanna Leventhal, Kimberly Meade‐White, et al.. (2024). A replicating RNA vaccine confers protection in a rhesus macaque model of Crimean-Congo hemorrhagic fever. npj Vaccines. 9(1). 86–86. 11 indexed citations

Leventhal, Shanna, Kimberly Meade‐White, Carl Shaia, et al.. (2024). Single dose, dual antigen RNA vaccines protect against lethal Crimean-Congo haemorrhagic fever virus infection in mice. EBioMedicine. 101. 105017–105017. 10 indexed citations

Leventhal, Shanna, Carl Shaia, Matthew Lewis, et al.. (2024). Replicating RNA vaccine confers durable immunity against Crimean Congo hemorrhagic fever virus challenge in mice. npj Vaccines. 9(1). 249–249. 2 indexed citations

10.

Meade‐White, Kimberly, et al.. (2023). CD8+ T-cells target the Crimean-Congo haemorrhagic fever virus Gc protein to control the infection in wild-type mice. EBioMedicine. 97. 104839–104839. 4 indexed citations

11.

Haddock, Elaine, Julie Callison, Stephanie N. Seifert, et al.. (2022). Three-Week Old Pigs Are Not Susceptible to Productive Infection with SARS-COV-2. Microorganisms. 10(2). 407–407. 4 indexed citations

12.

Hawman, David W., Kimberly Meade‐White, Shanna Leventhal, et al.. (2022). Accelerated DNA vaccine regimen provides protection against Crimean-Congo hemorrhagic fever virus challenge in a macaque model. Molecular Therapy. 31(2). 387–397. 22 indexed citations

13.

Leventhal, Shanna, Kimberly Meade‐White, Elaine Haddock, et al.. (2022). Replicating RNA vaccination elicits an unexpected immune response that efficiently protects mice against lethal Crimean-Congo hemorrhagic fever virus challenge. EBioMedicine. 82. 104188–104188. 46 indexed citations

14.

Rosenke, Kyle, Frederick Hansen, Benjamin Schwarz, et al.. (2021). Orally delivered MK-4482 inhibits SARS-CoV-2 replication in the Syrian hamster model. Nature Communications. 12(1). 2295–2295. 110 indexed citations

15.

Hawman, David W., Kimberly Meade‐White, Shanna Leventhal, et al.. (2021). Immunocompetent mouse model for Crimean-Congo hemorrhagic fever virus. eLife. 10. 35 indexed citations

16.

Leventhal, Shanna, Chad S. Clancy, Jesse H. Erasmus, Heinz Feldmann, & David W. Hawman. (2021). An Intramuscular DNA Vaccine for SARS-CoV-2 Decreases Viral Lung Load but Not Lung Pathology in Syrian Hamsters. Microorganisms. 9(5). 1040–1040. 6 indexed citations

17.

Hawman, David W., Kimberly Meade‐White, Shanna Leventhal, et al.. (2021). T-Cells and Interferon Gamma Are Necessary for Survival Following Crimean-Congo Hemorrhagic Fever Virus Infection in Mice. Microorganisms. 9(2). 279–279. 16 indexed citations

18.

Leventhal, Shanna, et al.. (2021). A Look into Bunyavirales Genomes: Functions of Non-Structural (NS) Proteins. Viruses. 13(2). 314–314. 49 indexed citations

19.

Rosenke, Kyle, Shanna Leventhal, Hong M. Moulton, et al.. (2020). Inhibition of SARS-CoV-2 in Vero cell cultures by peptide-conjugated morpholino oligomers. Journal of Antimicrobial Chemotherapy. 76(2). 413–417. 17 indexed citations

20.

Levin, M J, et al.. (1984). Factors influencing quantitative isolation of varicella-zoster virus. Journal of Clinical Microbiology. 19(6). 880–883. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact